Home Invites Members Groups Events Careers Videos News Photos Blogs Polls Forums Chat
Home > News > Post Content

N.C. A&T and Industry to Bring Novel Aspirin Derivatives to the Marketplace (363 hits)

Patients who require the benefits of aspirin without the accompanying stomach irritation are a step closer to comfort and cures with the signing of an exclusive licensing agreement. Dr. Shengmin Sang, a food scientist with North Carolina Agricultural and Technical State University, licensed his patent for a family of novel aspirin-derived compounds to SARISA Therapeutics, an Invenshure Company out of Minneapolis, Minnesota.

Sang’s patented compounds may be useful in treating or preventing colon cancer, heart disease and other disorders. Through this commercialization effort, more patients may be able to receive the benefits of aspirin without incurring adverse side effects.

“The timing of this agreement couldn’t be better for patients,” explains SARISA Therapeutics CEO Danny Cunagin. “Last April, the U.S. Preventive Services Task Force added colon cancer to the list of diseases for which aspirin should be prescribed as a preventive treatment. We aim to make Dr. Sang’s discoveries available to all patients who need aspirin’s therapeutic usefulness minus its gastric irritation side effects.”

Sang, a professor and lead scientist for functional foods in the College of Agriculture and Environmental Sciences, developed the new compounds at N.C. A&T’s Center for Excellence in Post-Harvest Technologies. “It is gratifying when our hard work is proven capable of improving people’s lives,” said Sang. “Our discoveries could be helpful in treating anything for which aspirin is recommended for treatment or prevention. Through our research, we have found it to be less toxic to the stomach than regular aspirin.”

Tests on colon cancer cell lines showed that Sang’s novel compounds, containing both aspirin and bioactive phytochemicals, were more effective at inducing cancer cell death than any of the individual components used alone or physically mixed. Sang describes his findings in the studies, “Novel Resveratrol-based Aspirin Prodrugs: Synthesis, Metabolism and Anticancer Activity,” published in the Journal of Medicinal Chemistry, and “Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer,” published in Scientific Reports. Funding for this, and other studies that gave rise to his patent and this commercialization agreement, came from the National Institutes of Health and the North Carolina Biotechnology Center.

SARISA Therapeutics, an Invenshure Company, seeks out emergent technologies to create partnerships, resulting in better care for patients. The company’s in-house scientists and engineers develop original Intellectual Property and augment existing ideas to accelerate and launch companies. Their proven expertise and networks translate scientific discovery into commercial reality.

Posted By: Elynor Moss
Monday, March 20th 2017 at 1:39PM
You can also click here to view all posts by this author...

Report obscenity | post comment
Share |
Please Login To Post Comments...

More From This Author
SPAN 279: BSU Study Abroad Spring 2018
Howard University Unveils New Bloomberg Lab
Blue Cross NC Announces $1 Million Investment in NCCU
Keshia Knight Pulliam to speak at Kentucky State University’s Women’s History Month Assembly
***The National Urban Economic Think Tank*** Register today
SAU Track And Field Team Honored At UNC-Texas A&M Basketball Tourney Game
Langston University hosts goat and hair sheep field day
UMBC assistant Eric Skeeters is thread to two of the biggest upsets in NCAA history
Forward This Article Entry!
News Home

(Advertise Here)
Who's Online
>> more | invite 
Latest Photos
>> more | add
Most Popular Bloggers
elynor moss has logged 93992 blog subscribers!
tanisha laverne grant has logged 51590 blog subscribers!
>> more | add 
Latest Member Activity
jasmin holmes just became a new member. 01:33PM
trentqual rhone just became a new member. 10:55AM
raymond gray just became a new member. 02:31PM
ashanti starks just became a new member. 11:49AM
cornelius turner just edited his profile. 12:29AM
amouri jones just became a new member. 01:17AM
rodaysha mccallum just became a new member. 05:17PM
reece wright just became a new member. 05:13PM
cassie jackson just edited her profile. 10:05PM
cassie jackson just answered a new question. 09:35PM
cassie jackson just became a new member. 09:32PM
kiendra williams just became a new member. 03:11PM
>> more | invite friends